Publication | Open Access

Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites

MedicinePathologyRosuvastatin-induced MyopathyGatm Gene VariantsMetabolomicsHigh Plasma ExposurePharmacologyOxidative Stress